Silence Therapeutics PLC banner

Intrinsic Value

Not Available for XRP2

There is not enough data to reliably calculate the intrinsic value for Silence Therapeutics PLC.

Do our valuations actually work? See backtest results .

Alternatives to XRP2

Fundamental Analysis

What Silence Therapeutics Does

Biotechnology Health Care

Silence Therapeutics PLC is a GB-based company operating in Biotechnology industry. Silence Therapeutics plc is a global clinical-stage biotechnology company engaged in transforming people’s lives by silencing diseases through precision-engineered medicines created with proprietary siRNA (short interfering RNA) technology. The firm leverages its mRNAi GOLD platform to create siRNAs designed to precisely target and silence disease-associated genes in the liver.

Headquarters
United Kingdom UK
Employees
88
IPO date
Jan 5, 2010
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue XRP2 Research

Decided on Silence Therapeutics? Get an email when XRP2 reaches the price you’d buy at. Free with an account.

Other Silence Therapeutics listings

Back to Top